Pneumagen

Developer of a treatment for viral respiratory tract infections and cancer

placeSt Andrews, Scotland, United Kingdom calendar_todayFounded 2016 groups7 employees language pneumagen.com

Registered entities

Innovation

16 patent families (5 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 266 times.

YearFilings
20182
20195
20206
20216
20225
20237
20243
20255

Social engagement

Social engagement: 884 social following, 2 posts in the last 12 months — below the industry typical range.

Investor mix

25 investors on record; lead investors include Scottish Investment Bank.

Investor typeCountShare
Venture capital14%
Private equity14%
Other / undisclosed2392%

Recent activity

17 Sep 2025
Product launch
NeumoBindTM technology platform
Coming soon